Hyderabad, April 21 :     Shanta Biotechnics Ltd has entered into a strategic alliance with multinational pharma giant Pfizer to market its cancer vaccine - Interferon- Sha-Feron in the US and Europe. Inaugurating the Rs 25 crore R&D centre of Shanta Biotechnics, about 35 kms from the city, A. P. J. Abdul Kalam Azad, defence advisor to the prime minister, said, 'The country is poised for research in chromosome decoding technology.' Varaprasad Reddy, managing director of Shanta Biotechnics' said today that the company was poised to enter the marine biotechnics arena. Shanta had 45 per cent of the Hepatitis-B vaccine market in the country worth about $ 15 million. 'Our cancer product - Interferon - will be launched in 2001 as its clinical testing on monkeys was disrupted by animal activists in 1999. Shanta is also poised to take up contract research for MNCs. Other products in the pipeline are a vaccine for Hepatitis-B and DTP and Vitamin C in collaboration with AIIMS,' he added.